Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
Rick Barry appointed Executive Chairman of the BoardRemi Barbier resigns as President and CEO and from the Board of DirectorsCassava…
Pharmaceuticals, Biotechnology and Life Sciences
Rick Barry appointed Executive Chairman of the BoardRemi Barbier resigns as President and CEO and from the Board of DirectorsCassava…
VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) — As a result of a review by the British Columbia Securities…
In a release issued under the same headline on July 12, 2024 by Onco360 Oncology Pharmacy, please note the change…
ORIC-944, a potential best-in-class PRC2 inhibitor, is being evaluated in combination with darolutamide and in combination with apalutamide in patients…
FOSTER CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical…
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…
LONG BEACH, Calif. and TORONTO, July 15, 2024 (GLOBE NEWSWIRE) — Glass House Brands Inc. (“Glass House” or the “Company”)…
– Prescription Drug User Fee Act (PDUFA) target action date is February 28, 2025 – – Product has patent protection…
NEW YORK and LEAMINGTON, Ontario, July 15, 2024 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY;…
SAN JOSE, Calif., July 15, 2024 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company…